Head-to-head comparison of (R)-[11C]verapamil and [18F]MC225 in non-human primates, tracers for measuring P-glycoprotein function.

European Journal of Nuclear Medicine and Molecular Imaging
Lara García-VarelaG Luurtsema

Abstract

P-glycoprotein (P-gp) function is altered in several brain disorders; thus, it is of interest to monitor the P-gp function in vivo using PET. (R)-[11C]verapamil is considered the gold standard tracer to measure the P-gp function; however, it presents some drawbacks that limit its use. New P-gp tracers have been developed with improved properties, such as [18F]MC225. This study compares the characteristics of (R)-[11C]verapamil and [18F]MC225 in the same subjects. Three non-human primates underwent 4 PET scans: 2 with (R)-[11C]verapamil and 2 with [18F]MC225, at baseline and after P-gp inhibition. The 30-min PET data were analyzed using 1-Tissue Compartment Model (1-TCM) and metabolite-corrected plasma as input function. Tracer kinetic parameters at baseline and after inhibition were compared. Regional differences and simplified methods to quantify the P-gp function were also assessed. At baseline, [18F]MC225 VT values were higher, and k2 values were lower than those of (R)-[11C]verapamil, whereas K1 values were not significantly different. After inhibition, VT values of the 2 tracers were similar; however, (R)-[11C]verapamil K1 and k2 values were higher than those of [18F]MC225. Significant regional differences between tracers ...Continue Reading

References

Aug 1, 1997·Journal of Pharmaceutical Sciences·J van AsperenJ H Beijnen
Feb 22, 2001·Journal of Neurochemistry·F C LamP B Reiner
Jan 24, 2002·Journal of Bioenergetics and Biomembranes·M M Gottesman, S V Ambudkar
Mar 21, 2002·Nature Reviews. Cancer·Michael M GottesmanSusan E Bates
Dec 1, 1959·The American Journal of Physiology·E M RENKIN
May 6, 2004·Journal of Molecular Neuroscience : MN·Cláudia PereiraCatarina Resende de Oliveira
Jul 14, 2005·Progress in Neurobiology·Wolfgang Löscher, Heidrun Potschka
Nov 7, 2008·Angewandte Chemie·Philip W MillerAntony D Gee
Jul 25, 2009·Clinical Pharmacology and Therapeutics·P KannanM D Hall
Aug 12, 2009·Neurobiology of Disease·N Joan AbbottDavid J Begley
Mar 10, 2010·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Pavitra KannanMatthew D Hall
Apr 27, 2010·Trends in Pharmacological Sciences·David S Miller
Sep 29, 2011·Annual Review of Pharmacology and Toxicology·M K DeGorterR B Kim
Feb 21, 2013·ACS Chemical Neuroscience·Stina Syvänen, Jonas Eriksson
Feb 3, 2015·Advances in Cancer Research·David S Miller
Feb 12, 2015·Clinical Pharmacology and Therapeutics·R M RaaphorstG Luurtsema
May 23, 2015·The International Journal of Neuroscience·Guang-Xin WangYan-Hui Ma
Jun 4, 2015·NeuroImage·Evan CalabreseG Allan Johnson
Jul 3, 2015·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Syahir MansorAdriaan Lammertsma
Oct 3, 2015·Nuclear Medicine and Biology·Jun ToyoharaKiichi Ishiwata
Nov 21, 2015·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Géraldine PottierNicolas Tournier
Mar 22, 2016·Expert Opinion on Drug Metabolism & Toxicology·Anne Mahringer, Gert Fricker
Jun 9, 2016·EJNMMI Physics·Maurizio Conti, Lars Eriksson
Jun 30, 2016·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Heli SavolainenGert Luurtsema
Jul 8, 2016·Journal of Clinical Pharmacology·Oliver Langer
Aug 16, 2016·Current Pharmaceutical Design·Maria Feldmann, Matthias Koepp
Aug 16, 2016·Current Pharmaceutical Design·Marcel Benadiba, Yehoshua Maor
Aug 30, 2016·Current Pharmaceutical Design·Gert LuurtsemaAren van Waarde
May 10, 2017·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·Massoud SaidijamSimon G Patching
May 12, 2018·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Sylvain AuvityNicolas Tournier
Jan 12, 2019·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Nicolas TournierOliver Langer
Dec 15, 2020·Molecular Pharmaceutics·Lara García-VarelaGert Luurtsema

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.